NIVF
Price:
$1.8
Market Cap:
$1.02M
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.
Industry
Medical - Healthcare Plans
IPO Date
2022-03-18
Stock Exchange
NASDAQ
Ticker
NIVF
According to NewGenIvf Group Limited’s latest financial reports and current stock price. The company's current ROE is 32.69%. This represents a change of 214.62% compared to the average of 10.39% of the last 4 quarters.
The mean historical ROE of NewGenIvf Group Limited over the last ten years is 18.28%. The current 32.69% ROE has changed 78.85% with respect to the historical average. Over the past ten years (40 quarters), NIVF's ROE was at its highest in in the September 2025 quarter at 57.27%. The ROE was at its lowest in in the December 2025 quarter at -28.80%.
Average
18.28%
Median
3.49%
Minimum
0.07%
Maximum
50.07%
Discovering the peaks and valleys of NewGenIvf Group Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.34%
Maximum Annual ROE = 50.07%
Minimum Annual Increase = -25.90%
Minimum Annual ROE = 0.07%
| Year | ROE | Change |
|---|---|---|
| 2025 | 37.10% | -25.90% |
| 2024 | 50.07% | 1.34% |
| 2023 | 3.49% | 419.14% |
| 2022 | 0.67% | 877.33% |
The current ROE of NewGenIvf Group Limited (NIVF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
30.22%
5-year avg
18.28%
10-year avg
18.28%
NewGenIvf Group Limited’s ROE is greater than SCWorx Corp. (-73.47%), greater than Hepion Pharmaceuticals, Inc. (-241.95%), less than ZyVersa Therapeutics, Inc. (0.81%), less than CDT Equity Inc. (2.59%), greater than INVO Fertility, Inc. (-471.55%), less than Envoy Medical, Inc. (129.49%), greater than PetVivo Holdings, Inc. (-256.06%), less than Concord Medical Services Holdings Limited (4.22%), less than Petros Pharmaceuticals, Inc. (266.79%), less than Longevity Health Holdings Inc. (158.86%),
| Company | ROE | Market cap |
|---|---|---|
| -73.47% | $303.46K | |
| -241.95% | $726.27K | |
| 0.81% | $1.71M | |
| 2.59% | $416.46K | |
| -471.55% | $2.67M | |
| 129.49% | $14.20M | |
| -256.06% | $21.16M | |
| 4.22% | $581.00K | |
| 266.79% | $239.93K | |
| 158.86% | $444.61K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NewGenIvf Group Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NewGenIvf Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NewGenIvf Group Limited's ROE?
How is the ROE calculated for NewGenIvf Group Limited (NIVF)?
What is the highest ROE for NewGenIvf Group Limited (NIVF)?
What is the 3-year average ROE for NewGenIvf Group Limited (NIVF)?
What is the 5-year average ROE for NewGenIvf Group Limited (NIVF)?
How does the current ROE for NewGenIvf Group Limited (NIVF) compare to its historical average?